Press Release
Stop Selling Hours, Start Selling Systems: Paul Bocco on Why AI Automation Is the Future of Service Business Growth
Charlotte, NC, 25th March 2026, ZEX PR WIRE — For decades, service-based professionals have built businesses around one core model: trading time for money. Consultants charge hourly rates, agencies bill monthly retainers tied to labor, and freelancers increase income primarily by working more hours. While this model has supported millions of professionals, entrepreneur and business strategist Paul Bocco believes the model itself is fundamentally flawed for long-term growth.
According to Paul Bocco, the future of service businesses will not be built on selling hours. It will be built on selling systems.
As the Founder of AI Profit Consulting, Paul Bocco is helping experienced professionals pivot into a rapidly growing opportunity: building recurring-revenue businesses by selling AI-powered automation systems to small and medium-sized companies.
His message to consultants, coaches, marketers, and sales professionals is simple but disruptive.
“Stop selling your time,” Paul Bocco often tells clients. “Start selling solutions that run without you.”
The Limits of the Hourly Model
Paul Bocco’s perspective comes from more than two decades of entrepreneurship. Since beginning his business journey in 2000, he has built six companies to multi–seven-figure revenue and worked with over 1,000 business owners across industries including marketing, e-commerce, coaching, and consumer financial services.
Throughout those years, he noticed a pattern.
Even successful service professionals eventually hit the same ceiling.
Their revenue is capped by how many hours they can personally work or manage. Growth often requires hiring employees, increasing operational complexity, and managing large teams. Profit margins shrink as labor costs rise, and burnout becomes common.
Paul Bocco believes AI is changing that equation.
“Technology is finally allowing small teams and even solo consultants to deliver massive value without massive workloads,” he explains.
Automation systems powered by artificial intelligence can now handle tasks that once required entire departments: customer communication, lead qualification, appointment booking, marketing follow-ups, and internal workflow management.
For businesses struggling to keep up with demand, these tools are not just convenient. They are transformative.
And that creates a new opportunity for consultants who understand how to implement them.
Selling Systems Instead of Services
At the core of Paul Bocco’s philosophy is a shift from labor-based services to results-driven systems.
Instead of offering ongoing hourly consulting, professionals can design AI-powered automation solutions that solve specific operational problems inside a business. Once implemented, these systems continue delivering value every day.
The result is a business model that produces recurring revenue without requiring constant manual work.
Through AI Profit Consulting, Paul Bocco trains sales professionals, consultants, and business owners to build automation consulting practices centered around this model.
Clients learn how to identify operational bottlenecks inside small and medium-sized businesses and implement AI solutions that improve efficiency, increase sales, or reduce labor costs.
In many cases, the systems deliver six-figure annual value to the companies using them.
“Businesses are already paying employees to do repetitive work that software can now handle faster and more accurately,” Paul Bocco says. “If you can implement the right system, the financial impact for the client can be enormous.”
Because of that impact, these automation solutions can command premium consulting fees and ongoing management retainers.
Paul Bocco notes that many of the systems his clients deploy add $150,000 or more in annual value per business.
“That level of ROI changes the entire sales conversation,” he explains. “You’re not selling hours. You’re selling outcomes.”
A New Opportunity for Experienced Professionals
One of the most surprising aspects of the AI automation consulting boom is who is best positioned to succeed in it.
According to Paul Bocco, the ideal candidates are not necessarily programmers or engineers. Instead, they are experienced sales professionals, consultants, and industry experts who already understand business problems.
“They already know how companies operate,” Paul Bocco says. “They understand where inefficiencies exist. AI tools simply give them a new way to solve those problems.”
Through his coaching program, participants learn how to package automation solutions, position them in the marketplace, and build consulting offers that generate recurring monthly revenue.
The goal is to help professionals transition from selling legacy products or traditional services to owning a modern AI-driven consulting business under the AI Profit Consultant brand.
While Paul Bocco previously built communities such as the Christian Business Incubator and Kingdom Business Incubator to serve faith-driven entrepreneurs, his current focus is centered on the AI Profit Consultant platform, which helps professionals launch and scale AI-powered consulting businesses.
Paul Bocco believes this shift represents one of the biggest entrepreneurial opportunities of the next decade.
“AI is moving faster than most businesses can adapt,” he says. “The people who understand how to implement it will be incredibly valuable.”
Systems Thinking From a Veteran Entrepreneur
Paul Bocco’s approach is rooted in his background in direct-response marketing and sales strategy.
Over the years, he has built a reputation for helping business owners focus on scalable systems rather than short-term tactics. His work has generated more than 300 video testimonials from clients who credit his frameworks for measurable growth.
This systems-focused mindset is what led Paul Bocco to recognize the potential of AI automation early. In a recently shared video discussing the Kingdom Business Incubator community, Paul Bocco reflects on how earlier initiatives helped entrepreneurs develop business skills and faith-driven leadership lessons that now inform his latest venture, AI Profit Consultant.
While many entrepreneurs initially viewed AI tools as novelty technologies, Bocco saw them as operational infrastructure.
“When you combine automation with strong marketing and sales processes, you can create businesses that scale much faster and with fewer people,” he says.
That philosophy now shapes the training inside AI Profit Consulting, where participants learn not only how to deploy AI tools but also how to structure profitable consulting offers around them.
A Faith-Driven Approach to Business
Despite his technology-focused work, Paul Bocco describes himself as a faith-driven entrepreneur.
He has previously built two businesses serving Christian entrepreneurs and continues to bring values such as integrity, stewardship, and service into the way he mentors business owners.
For him, business success is not just about revenue growth but also about impact.
“Entrepreneurship gives people the ability to create opportunity for themselves and others,” Paul Bocco says. “When done with integrity, it becomes a way to serve.”
That mindset also shapes how he works with clients. Many of the professionals entering his program are looking for more than just a profitable business model. They are seeking a way to build something meaningful and sustainable.
From Buffalo Roots to the AI Frontier
Originally from Buffalo, New York, Paul Bocco now operates from Charlotte, North Carolina, where he leads trainings, mentors clients, and continues developing new frameworks for AI-driven consulting businesses.
A graduate of SUNY Fredonia with a Bachelor of Science in Biology, he credits his analytical education with helping him approach business challenges methodically.
At the same time, he describes himself as a natural introvert who learned to step into leadership roles out of necessity as his businesses grew.
Today, that leadership extends to a global community of professionals learning how to build AI consulting practices under his guidance.
Outside of business, Paul Bocco is a devoted husband and father of two. He is also a lifelong Buffalo Bills fan and spends time coaching in his son’s flag football league.
The Next Evolution of Service Businesses
The rise of AI automation is already transforming how companies operate. Tasks that once required large teams can now be handled by software systems working around the clock.
For entrepreneurs like Paul Bocco, the shift represents more than just a technological upgrade. It represents a new economic model for service professionals.
Instead of scaling by adding employees, consultants can scale by building systems.
Instead of selling hours, they can sell outcomes.
And instead of chasing one-off projects, they can build predictable recurring revenue.
“Every major technology shift creates new industries,” Paul Bocco says. “AI automation consulting is one of them.”
For professionals willing to adapt, the opportunity may be one of the most significant business transformations in decades.
Contact
Paul Bocco
Founder, AI Profit Consulting
Charlotte, North Carolina, United States
LinkedIn: https://www.linkedin.com/in/paulboc/
Website: https://www.skool.com/ai-profit-consultant
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Nova Junk, a family-owned junk removal company based in Alexandria, Virginia, celebrates two decades of responsible hauling, recycling, and donation services across the Washington DC metro region.
Washington, United States, 16th Jul 2026 – Nova Junk, a locally owned junk removal company serving Washington, DC, Northern Virginia, and Maryland, is marking its 20th year in business. Founded on September 11, 2005, according to information published on the company website, the company has grown from a two-person family operation into a multi-service hauling company with a team that includes extended family members and long-tenured employees.
Nova Junk provides junk removal, estate cleanouts, office cleanouts, construction debris removal, yard debris hauling, shed removal, hot tub disposal, and labor-only services, according to the company website. The company serves communities throughout the Washington DC metro area, including Alexandria, Fairfax, Arlington, Bethesda, Montgomery County, and Prince George County.
A distinguishing feature of Nova Junk’s operating model is its three-stage disposal process: donate, recycle, and landfill. According to information published on the company website, the team sorts through all collected material, first setting aside items that can be donated to local charities and then separating recyclable materials such as batteries, printers, and refrigerators. Only the remainder goes to the landfill, and the company states that it typically sends just one third of collected material to the dump.
The company is licensed and fully insured, according to the company website, and places a strong emphasis on punctuality and transparent pricing. Nova Junk states that final charges are adjusted downward when a load turns out to be smaller than estimated, a policy highlighted repeatedly in customer reviews published on the company website.
“We started this company as a family and grew it the same way – by treating every customer’s home and business the way we would want ours treated,” said Norman Elbekri, Co-founder at Nova Junk. “After 20 years we are still committed to the same values we started with: honest pricing, responsible disposal, and service that people can count on.”
Nova Junk serves both residential and commercial clients. Services extend to de-cluttering and hoarding solutions, moving and foreclosure cleanouts, and demolition site cleanup. The company operates from two locations – 2000 Duke Street in Alexandria, Virginia and Smoketown Road in Woodbridge, Virginia – and can be reached at novajunk.com.
About Nova Junk
Nova Junk is a family-owned junk removal company founded in 2005, serving Washington, DC, Northern Virginia, and Maryland. The company provides residential and commercial hauling, estate cleanouts, construction debris removal, and specialty services including shed and hot tub removal. Nova Junk is committed to responsible disposal through a donate-recycle-landfill approach that minimizes landfill impact. Learn more at https://www.novajunk.com
Media Contact
Organization: Nova Junk
Contact Person: Norman Elbekri Co-founder
Website: https://www.novajunk.com/
Email:
info@novajunk.com
City: Washington
Country:United States
Release id:47175
The post Nova Junk marks 20 years of eco-friendly junk removal in the Washington DC area appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Jyong Biotech has updated its market entry strategy for innovative botanical pharmaceuticals, establishing multiple competitive advantages for its new drug portfolio
Jyong Biotech Ltd. (Nasdaq stock code: MENS) (hereinafter referred to as “the Company” or “Jyong Biotech”) is a science-driven biotechnology company dedicated to developing and commercializing innovative plant-based therapies. The Company recently announced that, following an analysis of the clinical efficacy and competitive advantages of its innovative botanical drugs Botreso® and PCP, it has advanced its market access strategy.
As previously announced by the company, its first core product, Botreso®, has completed four Phase III clinical trials (API-1) in the United States and Taiwan, while its second core product, PCP, has successfully completed a Phase II clinical trial. Overall clinical data demonstrate that Jyong Biotech’s innovative botanical drugs exhibit significant differentiation advantages compared to currently marketed synthetic chemical drugs.
Overall Safety Profile for Long-Term Use
For middle-aged and elderly males requiring long-term medication, safety is one of the most decisive factors. In clinical trials—Botreso® (Phase III) had a treatment duration of one year, while PCP (Phase II) lasted two years—no drug-related serious adverse events were observed, demonstrating excellent safety and tolerability.
In contrast, currently available chemically synthesized drugs for the treatment of benign prostatic hyperplasia (BPH) are often associated with adverse effects such as postural hypotension, erectile dysfunction, and decreased libido. Regulatory authorities and research institutions have linked certain synthetic alternative medications to significant risks, prompting the U.S. Food and Drug Administration (FDA) to issue a safety advisory regarding advanced prostate cancer and depression in 2011, and to include suicidal ideation in its list of adverse reactions in 2022. Additionally, an independent study conducted in 2021 also established associations between these drugs and cardiac failure.
Management of risks associated with advanced prostate cancer
Large-scale international clinical trials have demonstrated that while certain synthetic drugs used to treat benign prostatic hyperplasia (BPH) can reduce the overall incidence of prostate cancer, they may paradoxically increase the proportion of advanced prostate cancer (Grisson score ≥ 7) when cancer develops, thereby posing significant clinical safety concerns.
The Phase II clinical trial of PCP was a large-scale, long-term study on rare conditions conducted in Taiwan across 20 major hospitals. Over a period of two years, the trial involved 135 urologists (representing more than one-tenth of all urologists in Taiwan) and enrolled a total of 702 participants. It was one of the first global clinical trials specifically targeting prostate cancer prevention using a novel botanical drug conducted in Taiwan. The results demonstrated that PCP exhibited a downward trend in both overall prostate cancer incidence and the risk of advanced-stage prostate cancer, effectively addressing concerns within the medical community regarding the risks associated with existing therapies.
Comprehensive approach of “Treatment + Prevention + Metabolic Management”
Based on the clinical data from the company’s conducted trials, the company believes it is establishing a differentiated product positioning.
• Improvement of lower urinary tract symptoms (LUTS): Effectively alleviates symptoms associated with benign prostatic hyperplasia.
• Prevention of prostate cancer: Demonstrates prophylactic clinical potential.
• Metabolic and cardiovascular protection: Decreased triglyceride levels (P=0.05), significantly reduced total cholesterol and low-density lipoprotein (bad cholesterol) (P<0.05), significantly increased high-density lipoprotein (good cholesterol) (P<0.05), and maintained stable blood glucose levels.
This comprehensive therapy delivers benefits without adversely affecting blood pressure, liver function, or renal function. The company emphasizes that this integrated approach combining treatment, prevention, and metabolic management is exceptionally rare among current prostate medications and holds significant appeal for men aged 40 and above.
Technical Barriers and Competitive Advantages
Due to the inherent complexity and diversity of components in novel botanical drugs, quality control poses greater challenges compared to that of small-molecule chemical drugs. Jianyong Biotechnology asserts that the company has successfully established a comprehensive technical platform, which includes:
• Purification and establishment of reference standards.
• Development and validation of analytical methods.
• Perform the validation analysis and verification process.
The company believes that such comprehensive capabilities create substantial market entry barriers, rendering the products highly difficult to replicate. Furthermore, they effectively mitigate risks associated with competition from counterfeit and substandard products as well as generic drugs, ultimately contributing to an extended period of market monopoly.
The upgraded market positioning and strategic value
As a plant-based new drug protected by global patents, Jyong Biotech believes its market strategy leverages the following key advantages:
• Pricing competitiveness: Its unique metabolic protection profile and safety profile enable it to command higher prices compared to non-patented generic drugs, making it attractive to both out-of-pocket and high-end healthcare markets.
• Authorization potential: The combination of high tolerability, excellent safety profile (no serious adverse reactions), and multiple clinical benefits makes it an ideal target for international pharmaceutical collaboration.
• Market scalability: Expanding the product portfolio from treatment-oriented approaches to the fields of preventive medicine and health management.
Globally, over 500 million men aged 50 and above seek treatment for benign prostatic hyperplasia (BPH). In 2020, the global BPH drug market was valued at $4.1 billion and is projected to reach $9.8 billion by 2026. Although the current treatment market generates annual revenues of approximately $6.5 to $7 billion, this figure reflects price reductions due to patent expiration. If calculated based on prices during the patent period, the market potential exceeds $20 billion annually.
“Due to the complex composition of botanical new drugs, they face significant challenges in quality control compared to small-molecule chemical drugs,” stated Chairman Guo of Jianyong Biotechnology. “We have established a robust technical platform that encompasses the purification of reference standards, development and validation of analytical methods, as well as performance validation analyses. This high entry barrier makes counterfeiting difficult to achieve, reduces competition from generic drugs, and helps extend market exclusivity periods.”
Chairman Guo stated: “Botreso® is Taiwan’s first oral botanical drug to obtain an IND approval from the U.S. FDA for Phase III clinical trials (API-1) and has successfully completed all four Phase III clinical trials.”
Jyong Biotech holds multiple invention patents across Asia, the Americas, and the European Union, and has signed letters of intent and investment agreements with several international pharmaceutical companies. The company plans to further expand its strategic, fee-based licensing partnerships to support its global market expansion.
As of today, Botreso® and PCP remain in the investigational new drug candidate stage and have not yet been approved for commercial use in any jurisdiction. Jyong Biotech will comply with applicable regulatory disclosure obligations and provide timely, accurate, and complete updates on significant progress.
Company Profile: Jyong Biotech Ltd., headquartered in Taiwan, is a science-driven biotechnology company dedicated to the research, development, and commercialization of innovative and differentiated novel drugs (of plant origin), with a primary focus on the treatment of urinary system disorders, initially targeting the markets in the United States, the European Union, and Asia. Since its establishment in 2002, the company has developed comprehensive capabilities encompassing all critical stages of drug development, including early-stage drug discovery and development, pharmacology, toxicology, clinical trials, regulatory affairs, manufacturing, and commercialization. Leveraging robust R&D capabilities and proprietary platforms, the company has developed a portfolio of plant-derived candidate drugs, including its lead plant-based candidate Botreso®, another plant-based candidate drug in clinical development, and several other plant-based candidates in preclinical stages. The company is committed to developing and delivering cutting-edge innovative therapeutics to address customer health needs and strives to become a respected and valuable enterprise.
For more information, please contact:
Jyong Biotech Ltd.
ir@jyongbio.com
Investor Relations Department
WFS Investor Relations Inc.
Mailbox: services@wfsir.com
Phone: +1628 283 9214
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Experience the Future of Urban Mobility Firsthand: Tarran Presents the New L1 Series at Eurobike 2026
United States, 16th Jul 2026, – As the global cycling industry gathers in Frankfurt from June 24 to 27, 2026, TARRAN will exhibit at Booth F12 B26, where the company will debut the new L1 Series alongside its flagship model, the T1 Pro. Visitors can experience both models firsthand at the booth.
Following last year’s market launch of the T1 Pro, Tarran is expanding its portfolio, combining engineering precision with the demands of everyday urban riding.
Featured Models
L1 Series: New for 2026
The new model is engineered for practical everyday use. As TARRAN’s first intelligent longtail cargo bike designed for families, its core innovations include the industry-first SyncStand Auto, an electronic kickstand that parks the bike at the push of a button, and an E-Dropper Post that adjusts saddle height instantly.
Paired with Enviolo AUTOMATIQ Pro automatic shifting, fully integrated into TarranOS, the L1 delivers an intuitive, low-effort riding experience. It features a 100 Nm mid-drive motor, a removable 693 Wh battery built with Samsung cells, and a reinforced longtail frame supporting a maximum gross vehicle weight of 215 kg (474 lb).
For rider and passenger safety, the Vision Unit—combining a rear-view camera and mmWave radar—works together with integrated front and rear turn signals to provide 360-degree protection for the whole family. TARRAN continuously improves the L1 through over-the-air updates, supporting long-term product maintenance and ongoing refinement. A firmware update scheduled for late June will add native control for DJI action cameras and an anti-pinch safety function for the electronic kickstand.
T1 Pro
Successfully launched last year, the flagship model continues to demonstrate the brand’s technological strengths. The T1 Pro is equipped with active safety systems that monitor the bike’s surroundings and assist the rider in critical situations.
The T1 Pro features Tarran’s proprietary Dynamic Dualdrive landing gear, which stabilizes the bike while riding and at a standstill, reducing the risk of tipping. It is designed to carry families with two to three children in comfort, while its compact 2.26-meter (7.4 ft) overall length ensures agile handling.
Putting the Riding Experience First
Tarran believes that genuine innovation is best understood through direct experience. While the exhibit offers a closer look at the underlying technical architecture, consumers and e-bike enthusiasts are welcome to test ride both models directly at the TARRAN booth.
Visitors can see for themselves how the intuitive controls and safety features change the riding experience in urban environments.
Global Growth and Dealer Network
Reflecting TARRAN’s continued growth, and with the L1 Series now in series production, the brand’s products are available in more than 100 retail stores worldwide.
Strengthening its global footprint, TARRAN is now formally entering the North American market, actively building a dealer network across the United States and Canada to bring its intelligent, safety-focused cargo bikes to more families.
Expert Dialogue and Consultations
Tarran offers trade journalists and partners the opportunity for individual, in-depth background briefings. On-site experts will be available in the following areas:
Product Development and Technology: Shiyuan, Product Manager.
Strategy and Marketing: Dennis Wang and Larry Hu.
DACH Region Sales: Sebastian Locher and Jiaming Lee.
Benelux Region Sales: Fabian Hard.
Press Contact and Scheduling: To arrange a briefing or a test ride, please contact tarran@laika.berlin.
About TARRAN
Founded in 2023, TARRAN develops human-centered mobility experiences that combine clean energy with intelligent systems, with the goal of accelerating the transition to a more sustainable future.
The team draws on experience from leading technology companies, including DJI, and believes that technology can help solve real-world challenges while making a positive contribution to the world we live in.
TARRAN currently operates across three locations: Dusseldorf, Hong Kong, and Shenzhen. Its research, development, and testing center is located in Shenzhen, while its manufacturing hubs are situated in Europe and Southeast Asia.
Media Contact
Organization: Tarran GmbH
Contact
Person: Media Relations
Website:
https://tarranbikes.com/
Email:
store@tarranbikes.com
Contact Number: 8618898353598
Country:United States
The post
Experience the Future of Urban Mobility Firsthand: Tarran Presents the New L1 Series at Eurobike 2026 appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Nova Junk marks 20 years of eco-friendly junk removal in the Washington DC area
Jyong Biotech has updated its market entry strategy for innovative botanical pharmaceuticals, establishing multiple competitive advantages for its new drug portfolio
Experience the Future of Urban Mobility Firsthand: Tarran Presents the New L1 Series at Eurobike 2026
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release1 week ago
Vincere Portfolios Highlights Growing Shift Toward Algorithmic Futures Trading Among Independent Investors
-
Press Release5 days ago
Thriving in Retirement Michael Masor’s Newly Released Book is a Complete Blueprint for Modern Retirement Planning
-
Press Release6 days ago
SK Hynix ETFs – 2x Long (SKHX) & 1x Short (SKHZ) from Leverage Shares by Themes Arrive as ADRs Begin Trading
-
Press Release5 days ago
Ruckaroo Launches World’s First Fitness App Built for Weighted Walking
-
Press Release5 days ago
New Guide Helps Musicians Create a Connected Music Marketing System
-
Press Release6 days ago
Dubai Health and Rush University System for Health Announce Strategic Collaboration to Advance Quality of Care
-
Press Release5 days ago
JDLINO BRAND & FELITWO Celebrating El Champ — The Feroz Vargas and His Familión: A New Era in Boxing Power
-
Press Release5 days ago
Northlake Concierge Medical Center Announces Boutique Class-A Medical Office Development in Tucker, Georgia